Tasly Pharmaceutical Group Co., Ltd

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 8 466
EBIT TTM (mln): 1 173
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 253 392 685 930 1,056 1,302 1,466 2,414 2,795 3,434 3,993 4,652 6,570 9,301 11,108 12,580 13,228 13,945 16,094 17,990 18,998 13,576 7,952 8,593 8,674 8,498
Przychód Δ r/r 0.0% 54.8% 74.8% 35.8% 13.5% 23.3% 12.6% 64.7% 15.8% 22.9% 16.3% 16.5% 41.2% 41.6% 19.4% 13.3% 5.1% 5.4% 15.4% 11.8% 5.6% -28.5% -41.4% 8.1% 0.9% -2.0%
Marża brutto 87.2% 78.7% 77.5% 78.2% 72.4% 60.9% 54.0% 35.1% 32.9% 33.2% 32.7% 33.7% 30.0% 30.7% 36.6% 37.5% 38.8% 36.5% 36.3% 36.2% 31.3% 40.7% 66.3% 64.0% 66.7% 67.1%
EBIT (mln) 87 100 130 147 178 217 232 263 214 317 391 536 742 936 1,401 1,709 1,747 1,466 1,745 1,945 1,838 1,472 2,733 1,274 1,228 1,076
EBIT Δ r/r 0.0% 14.0% 30.8% 12.7% 21.0% 22.0% 6.7% 13.4% -18.6% 48.4% 23.4% 36.9% 38.5% 26.1% 49.8% 22.0% 2.2% -16.1% 19.0% 11.5% -5.5% -19.9% 85.6% -53.4% -3.6% -12.4%
EBIT (%) 34.6% 25.4% 19.0% 15.8% 16.8% 16.7% 15.8% 10.9% 7.6% 9.2% 9.8% 11.5% 11.3% 10.1% 12.6% 13.6% 13.2% 10.5% 10.8% 10.8% 9.7% 10.8% 34.4% 14.8% 14.2% 12.7%
Koszty finansowe (mln) 0 6 10 13 14 26 46 51 41 71 42 62 77 109 163 302 267 232 317 487 451 287 77 64 87 65
EBITDA (mln) 90 107 150 181 228 295 336 390 371 505 548 737 1,007 1,313 1,833 2,260 2,406 2,044 2,475 2,936 2,225 2,417 3,586 1,791 1,809 1,626
EBITDA(%) 35.5% 27.4% 22.0% 19.5% 21.6% 22.7% 22.9% 16.1% 13.3% 14.7% 13.7% 15.9% 15.3% 14.1% 16.5% 18.0% 18.2% 14.7% 15.4% 16.3% 11.7% 17.8% 45.1% 20.8% 20.9% 19.1%
Podatek (mln) 25 22 26 28 34 41 37 48 62 64 75 96 146 168 252 283 272 277 334 364 328 367 316 180 204 210
Zysk Netto (mln) 59 80 103 118 141 171 194 206 178 256 317 450 611 769 1,100 1,368 1,479 1,176 1,377 1,545 1,001 1,126 2,359 -341 1,071 956
Zysk netto Δ r/r 0.0% 35.2% 29.3% 14.6% 19.8% 21.3% 13.0% 6.2% -13.5% 44.0% 23.8% 42.2% 35.6% 25.9% 43.0% 24.4% 8.1% -20.4% 17.0% 12.2% -35.2% 12.4% 109.5% -114.4% -414.3% -10.8%
Zysk netto (%) 23.3% 20.3% 15.0% 12.7% 13.4% 13.2% 13.2% 8.5% 6.4% 7.5% 7.9% 9.7% 9.3% 8.3% 9.9% 10.9% 11.2% 8.4% 8.6% 8.6% 5.3% 8.3% 29.7% -4.0% 12.3% 11.2%
EPS 0.0461 0.0623 0.0806 0.0716 0.0857 0.1 0.15 0.16 0.14 0.19 0.23 0.33 0.42 0.59 0.76 0.94 0.99 0.78 0.91 1.02 0.66 0.75 1.57 -0.23 0.72 0.64
EPS (rozwodnione) 0.0461 0.0623 0.0806 0.0716 0.0857 0.1 0.15 0.16 0.14 0.19 0.23 0.33 0.42 0.59 0.76 0.94 0.99 0.78 0.91 1.02 0.66 0.75 1.57 -0.23 0.72 0.64
Ilośc akcji (mln) 1,276 1,276 1,276 1,276 1,276 1,276 1,276 1,272 1,370 1,378 1,364 1,370 1,449 1,452 1,450 1,451 1,496 1,511 1,513 1,508 1,508 1,503 1,502 1,495 1,488 1,493
Ważona ilośc akcji (mln) 1,276 1,276 1,276 1,276 1,276 1,276 1,276 1,272 1,370 1,378 1,364 1,370 1,449 1,452 1,450 1,451 1,500 1,511 1,513 1,515 1,508 1,503 1,502 1,495 1,494 1,493
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY